Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency
Abstract
J Clin Immunol (2017) 37:613 DOI 10.1007/s10875-017-0418-2 ERRATUM Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency 1 2 3 4 Richard L. Wasserman & Isaac R. Melamed & Mark R. Stein & Stephen Jolles & 5 6 Miranda Norton & James N. Moy & for the GMX07 Study Group Published online: 17 July 2017 The Author(s) 2017. This article is an open access publication...